Back

Reproducibility of Apparent Diffusion Coefficient and Restriction Spectrum Imaging Restriction Score in the Prostate Across MRI Sessions, Vendors, and Acquisition Settings: a Prospective Study

song, y.; Conlin, C. C.; Lee, K.-L.; Dornisch, A.; Barrett, T.; Do, S.; Do, D. D.; Margolis, D. J.; Rakow-Penner, R.; Dale, A.; Liss, M. A.; Seibert, T. M.

2026-05-13 radiology and imaging
10.64898/2026.05.10.26352843 medRxiv
Show abstract

BackgroundDiffusion-weighted MRI is central to prostate cancer detection, but apparent diffusion coefficient (ADC) has limited reproducibility across scanners and sites. Restriction Spectrum Imaging restriction score maximum value (RSIrs-max) may provide a more reproducible biomarker. PurposeTo evaluate cross-session reproducibility of within-lesion mean ADC and RSIrs-max on prostate MRI, including same-vendor and cross-vendor comparisons, and in unfavorable-histology prostate cancer (uhPC) and different interpolation settings. Materials and MethodsIn this prospective study, participants with suspected or known prostate cancer enrolled from August 2022 to January 2026 underwent two MRI examinations including an RSI protocol. MRI-visible lesions were contoured on T2-weighted MRI; in participants with multiple lesions, the index lesion was selected. Mean ADC and RSIrs-max were measured within MRI-visible lesions. Analyses included all visible lesions, same-vendor and cross-vendor subgroups, participants with uhPC, and 20 participants with scans reconstructed with and without zero-filled interpolation (a setting with different defaults across vendors). Pearson correlation coefficients with 10,000 bootstrap resamples were used to estimate 95% confidence intervals. ResultsSixty-one male participants (median age, 69 years [IQR, 63-74]) were evaluated; 58 of 61 (95%) had MRI-visible lesions, and 26 of 58 (45%) had uhPC. For all MRI-visible lesions, correlations were 0.55 (95% CI: 0.23-0.76) for mean ADC and 0.83 (95% CI: 0.72-0.90) for RSIrs-max. In same-vendor scans, correlations were 0.76 (95% CI: 0.27-0.95) and 0.88 (95% CI: 0.72-0.96); in cross-vendor scans, they were 0.31 (95% CI: -0.07-0.62) and 0.79 (95% CI: 0.65-0.89), respectively. In uhPC, correlations were 0.42 (95% CI: -0.02-0.83) for mean ADC and 0.90 (95% CI: 0.77-0.96) for RSIrs-max. With inconsistent versus consistent interpolation, RSIrs-max correlation increased from 0.73 (95% CI: 0.48-0.89) to 0.89 (95% CI: 0.78-0.96). ConclusionADC showed limited reproducibility, particularly across vendors. RSIrs-max has stronger between-session reproducibility across same-vendor, cross-vendor, uhPC, and interpolation analyses.

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.

1
Journal of Magnetic Resonance Imaging
14 papers in training set
Top 0.1%
55.0%
50% of probability mass above
2
Magnetic Resonance in Medicine
72 papers in training set
Top 0.3%
4.1%
3
Scientific Reports
3102 papers in training set
Top 32%
3.8%
4
European Radiology
14 papers in training set
Top 0.2%
3.8%
5
NMR in Biomedicine
24 papers in training set
Top 0.2%
3.2%
6
Magnetic Resonance Imaging
21 papers in training set
Top 0.2%
2.7%
7
Diagnostics
48 papers in training set
Top 0.6%
2.5%
8
PLOS ONE
4510 papers in training set
Top 49%
2.0%
9
Analytical Biochemistry
26 papers in training set
Top 0.1%
1.4%
10
Nature Communications
4913 papers in training set
Top 54%
1.4%
11
Neuro-Oncology Advances
24 papers in training set
Top 0.3%
1.3%
12
Scientific Data
174 papers in training set
Top 2%
1.2%
13
Frontiers in Oncology
95 papers in training set
Top 3%
1.0%
14
Human Brain Mapping
295 papers in training set
Top 4%
0.9%
15
Imaging Neuroscience
242 papers in training set
Top 3%
0.9%
16
NeuroImage: Clinical
132 papers in training set
Top 3%
0.8%
17
NeuroImage
813 papers in training set
Top 5%
0.8%
18
BMC Medicine
163 papers in training set
Top 6%
0.8%
19
Radiotherapy and Oncology
18 papers in training set
Top 0.3%
0.8%
20
eBioMedicine
130 papers in training set
Top 4%
0.8%
21
JAMA Network Open
127 papers in training set
Top 4%
0.8%
22
Biology Methods and Protocols
53 papers in training set
Top 2%
0.8%
23
Frontiers in Computational Neuroscience
53 papers in training set
Top 2%
0.8%